Innocare Pharma Limited Stock Market Value
| INCPF Stock | USD 2.05 0.00 0.00% |
| Symbol | InnoCare |
InnoCare Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to InnoCare Pharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of InnoCare Pharma.
| 10/24/2025 |
| 01/22/2026 |
If you would invest 0.00 in InnoCare Pharma on October 24, 2025 and sell it all today you would earn a total of 0.00 from holding InnoCare Pharma Limited or generate 0.0% return on investment in InnoCare Pharma over 90 days. InnoCare Pharma is related to or competes with Shanghai Junshi, Genscript Biotech, ALK Abell, Laboratorios Farmaceuticos, Zealand Pharma, Camurus AB, and Fielmann Aktiengesellscha. InnoCare Pharma Limited, a clinical stage biopharmaceutical company, focuses on discovering, developing, and commerciali... More
InnoCare Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure InnoCare Pharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess InnoCare Pharma Limited upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.20) | |||
| Maximum Drawdown | 29.14 |
InnoCare Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for InnoCare Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as InnoCare Pharma's standard deviation. In reality, there are many statistical measures that can use InnoCare Pharma historical prices to predict the future InnoCare Pharma's volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.62) | |||
| Total Risk Alpha | (1.13) | |||
| Treynor Ratio | 2.72 |
InnoCare Pharma January 22, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | 2.73 | |||
| Mean Deviation | 1.21 | |||
| Coefficient Of Variation | (593.89) | |||
| Standard Deviation | 3.78 | |||
| Variance | 14.26 | |||
| Information Ratio | (0.20) | |||
| Jensen Alpha | (0.62) | |||
| Total Risk Alpha | (1.13) | |||
| Treynor Ratio | 2.72 | |||
| Maximum Drawdown | 29.14 | |||
| Skewness | (7.17) | |||
| Kurtosis | 53.8 |
InnoCare Pharma Backtested Returns
InnoCare Pharma holds Efficiency (Sharpe) Ratio of -0.17, which attests that the entity had a -0.17 % return per unit of risk over the last 3 months. InnoCare Pharma exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out InnoCare Pharma's Risk Adjusted Performance of (0.12), standard deviation of 3.78, and Market Risk Adjusted Performance of 2.73 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of -0.24, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning InnoCare Pharma are expected to decrease at a much lower rate. During the bear market, InnoCare Pharma is likely to outperform the market. At this point, InnoCare Pharma has a negative expected return of -0.64%. Please make sure to check out InnoCare Pharma's variance, skewness, as well as the relationship between the Skewness and day typical price , to decide if InnoCare Pharma performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.84 |
Very good predictability
InnoCare Pharma Limited has very good predictability. Overlapping area represents the amount of predictability between InnoCare Pharma time series from 24th of October 2025 to 8th of December 2025 and 8th of December 2025 to 22nd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of InnoCare Pharma price movement. The serial correlation of 0.84 indicates that around 84.0% of current InnoCare Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.84 | |
| Spearman Rank Test | 0.49 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
Other Information on Investing in InnoCare Pink Sheet
InnoCare Pharma financial ratios help investors to determine whether InnoCare Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in InnoCare with respect to the benefits of owning InnoCare Pharma security.